Investigating the role of pharmacogenomics in optimizing medication therapy for pregnant women: a pilot study
Year: 2025
Type: article
Abstract: Each medication that is ordinarily used during pregnancy needs to go through an escalated pharmacokinetic examination. It is trying for a clinician to close whether a prescription's benefits offset its perils when it hasn't been evaluated. Basic thought should be given to getting taught consent, recording patient characteristics, recording drug piece and range, assessing plasma drug levels, and conveying the experience as a case report when clinicians decide to regulate medications that needy individual been completely focused on in pregnancy. Clinicians can augment treatment ampleness by preventing underdosing and limiting overabundance with the associated opposing effects by including improved dosing rules for pregnant patients. Most importantly, specialists could underwrite better medications for the best outcomes and success for both the mother and the undeveloped organism. The most often used intravenous enemy of contamination during pregnancy is cefazolin, which is cleared even more quickly due to extended renal excretion.[10] to stay aware of plasma obsessions above MIC during operation, a higher starting piece and more progressive association are required due to cefazolin's extended volume of movement during pregnancy and its accelerated opportunity.
Source: Journal of Neonatal Surgery
Authors: Chandra Pratap Dhimar, Aayush Vaishnaw
Institution: Kalinga University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4407858282